Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death

Purpose To identify and analyze postmarketing cases of complex sleep behaviors (CSBs) resulting in serious injuries, including death, associated with eszopiclone, zaleplon, or zolpidem (Z‐drugs). Methods Retrospective analysis of the U.S. Food and Drug Administration (FDA) Adverse Event Reporting Sy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacoepidemiology and drug safety 2020-06, Vol.29 (6), p.684-691
Hauptverfasser:	Harbourt, Kelly, Nevo, Ofir N., Zhang, Rongmei, Chan, Vicky, Croteau, David
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetamides - adverse effects Adult Adverse Drug Reaction Reporting Systems Aged Carbon monoxide complex sleep behaviors Death Drug Labeling eszopiclone Eszopiclone - adverse effects Female Humans Hypothermia Male Middle Aged non‐rapid eye movement (NREM) parasomnias Overdose Parasomnias - chemically induced Parasomnias - mortality Parasomnias - physiopathology pharmacoepidemiology Pharmacovigilance Public health Pyrimidines - adverse effects Retrospective Studies Risk Assessment Risk Factors serious injuries Sleep Sleep - drug effects Sleep Aids, Pharmaceutical - adverse effects Sleep Initiation and Maintenance Disorders - diagnosis Sleep Initiation and Maintenance Disorders - drug therapy Sleep Initiation and Maintenance Disorders - physiopathology Somnambulism - chemically induced Somnambulism - mortality Somnambulism - physiopathology Statistical analysis Statistical sampling Suicide Suicides & suicide attempts Time Factors Treatment Outcome Wounds and Injuries - chemically induced Wounds and Injuries - mortality Wounds and Injuries - physiopathology Zaleplon Zolpidem Zolpidem - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!